BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12735590)

  • 21. [Open heart surgery using cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia(HIT)].
    Furukawa H; Konishi T; Fukata M; Okada H; Sakagami N; Kurosaki K
    Kyobu Geka; 2013 May; 66(5):383-6. PubMed ID: 23674036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
    Treschan TA; Schaefer MS; Geib J; Bahlmann A; Brezina T; Werner P; Golla E; Greinacher A; Pannen B; Kindgen-Milles D; Kienbaum P; Beiderlinden M
    Crit Care; 2014 Oct; 18(5):588. PubMed ID: 25344113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Argatroban for anticoagulation during cardiopulmonary bypass in a patient with heparin allergy.
    Smith AI; Stroud R; Damiani P; Vaynblat M
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1113-4. PubMed ID: 18760617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of argatroban during cardiopulmonary bypass for atrial septal defect with heparin induced thrombocytopenia after introduction of dialysis].
    Ishida H; Yamazaki T
    Kyobu Geka; 2009 Feb; 62(2):122-4. PubMed ID: 19202931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Argatroban therapy in heparin-induced thrombocytopenia.
    Sparks ML
    AACN Adv Crit Care; 2009; 20(1):37-43. PubMed ID: 19174636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
    Lewis BE; Walenga JM; Wallis DE
    Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged elevation of plasma argatroban in a cardiac transplant patient with a suspected history of heparin-induced thrombocytopenia with thrombosis.
    Genzen JR; Fareed J; Hoppensteadt D; Kurup V; Barash P; Coady M; Wu YY
    Transfusion; 2010 Apr; 50(4):801-7. PubMed ID: 20003049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between hirudin and activated clotting time: implications for patients with heparin-induced thrombocytopenia undergoing cardiac surgery.
    Despotis GJ; Hogue CW; Saleem R; Bigham M; Skubas N; Apostolidou I; Qayum A; Joist JH
    Anesth Analg; 2001 Jul; 93(1):28-32. PubMed ID: 11429333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
    Lewis BE; Wallis DE; Berkowitz SD; Matthai WH; Fareed J; Walenga JM; Bartholomew J; Sham R; Lerner RG; Zeigler ZR; Rustagi PK; Jang IK; Rifkin SD; Moran J; Hursting MJ; Kelton JG;
    Circulation; 2001 Apr; 103(14):1838-43. PubMed ID: 11294800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
    Burger CF; Schlesinger JJ
    Ann Pharmacother; 2014 Feb; 48(2):286-91. PubMed ID: 24259642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case series.
    Nuttall GA; Oliver WC; Santrach PJ; McBane RD; Erpelding DB; Marver CL; Zehr KJ
    Anesth Analg; 2003 Feb; 96(2):344-50, table of contents. PubMed ID: 12538175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Argatroban usage for anticoagulation for ECMO on a post-cardiac patient with heparin-induced thrombocytopenia.
    Mejak B; Giacomuzzi C; Heller E; You X; Ungerleider R; Shen I; Boshkov L
    J Extra Corpor Technol; 2004 Jun; 36(2):178-81. PubMed ID: 15334762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case series describing the use of argatroban in patients on extracorporeal circulation.
    Cornell T; Wyrick P; Fleming G; Pasko D; Han Y; Custer J; Haft J; Annich G
    ASAIO J; 2007; 53(4):460-3. PubMed ID: 17667231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of cangrelor with heparin for left ventricular assist device implantation in a patient with acute heparin-induced thrombocytopenia.
    Gernhofer YK; Ross M; Khoche S; Pretorius V
    J Cardiothorac Surg; 2018 Apr; 13(1):30. PubMed ID: 29665860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Argatroban as a heparin substitute in cases of heparin-induced thrombocytopenia.
    Shrager JB; Kaiser LR
    Ann Thorac Surg; 2004 Dec; 78(6):2208; author reply 2208-9. PubMed ID: 15561082
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiopulmonary Bypass Without Heparin.
    Rehfeldt KH; Barbara DW
    Semin Cardiothorac Vasc Anesth; 2016 Mar; 20(1):40-51. PubMed ID: 26872706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of argatroban for carotid endarterectomy in heparin-induced thrombocytopenia.
    Hallman SE; Hebbar L; Robison J; Uber WE
    Anesth Analg; 2005 Apr; 100(4):946-948. PubMed ID: 15781503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview of heparin-induced thrombocytopenia.
    Donovan JL; Tran MT; Kanaan AO
    J Pharm Pract; 2010 Jun; 23(3):226-34. PubMed ID: 21507818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of Cardiovascular Surgery Utilizing Heparin versus Direct Thrombin Inhibitors in Cardiopulmonary Bypass in Patients with Previously Diagnosed HIT.
    Carlson DS; Bartholomew JR; Gomes MP; McCrae KR; Chaturvedi S
    Thromb Haemost; 2020 Feb; 120(2):300-305. PubMed ID: 31887779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.